Laboratorio Reig Jofre, S.A. (BME:RJF)

Spain · Delayed Price · Currency is EUR

2.600

-0.040 (-1.52%)

At close: Feb 27, 2026

-1.89% (1Y)

Market Cap	211.62M
Revenue (ttm)	330.34M
Net Income (ttm)	4.25M
Shares Out	81.39M
EPS (ttm)	0.05
PE Ratio	49.79
Forward PE	26.00
Dividend	0.05 (1.86%)
Ex-Dividend Date	May 15, 2025

Volume	48,477
Average Volume	24,277
Open	2.640
Previous Close	2.640
Day's Range	2.590 - 2.640
52-Week Range	2.500 - 3.400
Beta	0.99
RSI	40.02
Earnings Date	Feb 27, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements und... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1929

Employees 1,426

Stock Exchange Madrid Stock Exchange

Ticker Symbol RJF

Full Company Profile

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.

Financial Statements

News

There is no news available yet.